Investment analysis, share recommendations, and market insights.
For the week ending Friday 17 April 2026, FNArena recorded 15 upgrades and 15 downgrades from the seven brokers monitored daily across ASX-listed companies.
I see daily evidence of companies, large and small using AI to do more things with the same or fewer people. The cost savings could be larger than the market expects. Having reviewed more than a dozen AI-related ETFs for this column, here are two worth considering at current prices.
Michael Gable, Managing Director of Fairmont Equities, explains why Mineral Resources (MIN) is a buy for those investors looking to get in early.
With the takeover offer for Monash IVF, is the potential rejection a case of "the Board looking after itself" rather than acting in the best interest of all shareholders? What are the biggest companies in the Betashares Australian Technology ETF? Do the brokers think APA Group is a buy? When calculating the minimum super pension to take, do I use my age at the start of the year or during the year?
If you have a vested interest in what various ASX companies are digging up and selling, today's episode is for you!
Here's my pick of stocks that could have upside when peace is given a chance.
Term deposit rates have hit a five-year high. Here's how to make the most out of what's on offer.
As the share market gyrates around the expected impact of the Iran War, a small group of companies are experiencing a benefit. Here are two more such situations.
Raymond Chan comments that Morgans has updated its recommendation for Sigma Healthcare (SIG) from ACCUMULATE to BUY.
Opportunities always exist in strong and weak markets. Here are opportunities from this Iran war for portfolio investors with a higher risk appetite. Three potential long-term beneficiaries from the Iran war at a country and sector level.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.